Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium picosulfate 5mg/5ml oral solution sugar free
0106020P0AAABAB
|
Sodium picosulfate | Sodium picosulfate | Gastro-Intestinal System | 50,799 |
|
Dulcolax Pico Adult 5mg/5ml liquid
0106020P0BDACAB
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | 4,720 |
|
Picolax oral powder 16.1g sachets
0106050S0BBABAA
|
Picolax | Sodium picosulfate | Gastro-Intestinal System | 2,762 |
|
Dulcolax Pico Twelve 5mg/5ml liquid
0106020P0BDADAB
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | 326 |
|
Generic Picolax oral powder 16.1g sachets sugar free
0106050S0AAAAAA
|
Sodium picosulfate (Bowel Cleansing) | Sodium picosulfate | Gastro-Intestinal System | 64 |
|
CitraFleet oral powder 15.08g sachets
0106050S0BCABA0
|
CitraFleet | Sodium picosulfate | Gastro-Intestinal System | 31 |
|
Sodium picosulfate 2.5mg capsules
0106020P0AAAFAF
|
Sodium picosulfate | Sodium picosulfate | Gastro-Intestinal System | 4 |
|
Crescent Pharma Liquid Laxative 5mg/5ml oral solution
0106020P0BFAAAB
|
Crescent Pharma | Sodium picosulfate | Gastro-Intestinal System | 2 |
|
CitraFleet oral powder 16.11g sachets
0106050S0BCAAA0
|
CitraFleet | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
Dulcolax Pico 2.5mg Perles
0106020P0BDABAF
|
Dulcolax (Sodium picosulfate) | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
OTC Concepts Liquid Laxative 5mg/5ml oral solution
0106020P0BEAAAB
|
OTC Concepts | Sodium picosulfate | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.